BridgeMD
New treatment option for Multiple Sclerosis (MS)
Official title Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences
ClinicalTrials.gov ID: NCT04819737
What this study is testing
- What it's testing
- This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of multiple sclerosis according to established international criteria
- Steroid free period: \> 4 weeks
- Participation in the Swiss MS Cohort (SMSC) study
You likely can't join if
- . History of severe (other) neurological, internal or psychiatric disease with SC affection
- MRI-related exclusion criteria (questionnaire):
- Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)
- Pacemaker
- Claustrophobia
- Pregnancy, lactation
See the full eligibility criteria
- Diagnosis of multiple sclerosis according to established international criteria
- Steroid free period: \> 4 weeks
- Participation in the Swiss MS Cohort (SMSC) study
- . History of severe (other) neurological, internal or psychiatric disease with SC affection
- MRI-related exclusion criteria (questionnaire):
- Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)
- Pacemaker
- Claustrophobia
- Pregnancy, lactation
- Known hypersensitivity to gadolinium-based contrast media
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.